IRX-5010

N/A

Report date: 2026/01/08 17:58:13
NME

Base Information

Drug NameIRX-5010
Drug Alias NameIRX5010IRX-5010IRX4647FIRX-4647-F
ClassificationSmall molecules
Mechanisms of ActionRetinoic acid receptor gamma agonists
TargetsRetinoic acid receptor gamma
Therapy Area/IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungColorectal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesIo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungColorectal Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A